A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effect of the fixed combination of
valsartan+hydrochlorothiazide (HCTZ) on blood pressure reduction with valsartan and HCTZ
alone and whether the combination treatments are safe and well tolerated. The study aims to
establish a dose response relationship for both monotherapies and the combinations.
This study is being conducted in Japan.